Author | Ziad Bakouny, MD, MSc | OncLive

Author | Ziad Bakouny, MD, MSc


Dr. Bakouny on the Utility of Checkpoint Inhibitors in Sarcomatoid RCC

April 02, 2020


Ziad Bakouny, MD, MSc, discusses the utility of checkpoint inhibitors in renal cell carcinoma with sarcomatoid differentiation.

Dr. Bakouny on the Role of Cytoreductive Nephrectomy in mRCC

February 19, 2020


Ziad Bakouny, MD, MSc, discusses the role of cytoreductive nephrectomy in metastatic renal cell carcinoma.

New Perioperative Strategies Emerge for High-Risk, Resectable RCC

December 04, 2019


The current management of metastatic renal cell carcinoma reflects the progress of medical oncology throughout the past several decades. The standard of care has evolved from cytokine-based therapies to targeted molecular therapies and immune checkpoint inhibitor–based strategies.

Investigators Seek Expanded Use of Checkpoint Inhibitors in RCC

December 05, 2018


In contrast to the wide array of available therapies in the metastatic setting of renal cell carcinoma, in patients with localized disease, the results of trials investigating adjuvant systemic therapy after nephrectomy have so far been underwhelming.